SEC Form 4 · accession 0000914190-26-000110
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur H Amron
Director
Period of report
Aug 12, 2026
Accepted (ET)
Aug 14, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 12, 2026 | A | 2,418 | $0.00 | A | 140,874 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.14 | holding | — | — | — | — | May 14, 2034 | Common Stock | 7,323 | 7,323 | D |
| Stock Option (Right to Buy)F3 | $1.47 | holding | — | — | — | — | Jan 1, 2035 | Common Stock | 7,050 | 7,050 | D |
Explanation of responses
- F1Shares issued to reporting person in lieu of cash fees for board service.
- F2Fully vested.
- F3This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.